Concepedia
Statistics
Publications
212
Citations
17K
H-Index
54
Active since
1993
Affiliations
University of British Columbia(Current)
Vancouver General Hospital
University of Alberta
University of Toronto
BC Centre for Disease Control
Eric M. Yoshida is an author at University of British Columbia specializing in medicine, pharmacotherapy, and viral hepatitis.
Publications per year
1993–2022
Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection
Ira M. Jacobson, John G. McHutchison, Geoffrey Dusheiko et al. · New England Journal of Medicine · 2011 · 2.4K citations · Full text
Pharmacy, Infectious Diseases, Pharmacotherapy +17
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
Zobair M. Younossi, Vlad Ratziu, Rohit Loomba et al. · The Lancet · 2019 · 1.2K citations · Full text
Medicine, Internal Medicine, Pharmacology +8
Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection
Jordan J. Feld, Ira M. Jacobson, Christophe Hézode et al. · New England Journal of Medicine · 2015 · 1.1K citations · Full text
Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options
Ira M. Jacobson, Stuart C. Gordon, Kris V. Kowdley et al. · New England Journal of Medicine · 2013 · 1.1K citations · Full text
Pharmacy, Infectious Diseases, Pharmacotherapy +15
ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin for Hepatitis C with Cirrhosis
Fred Poordad, Christophe Hézode, Roger Trinh et al. · New England Journal of Medicine · 2014 · 877 citations · Full text
Pharmacy, Pharmacology, Pharmacotherapy +17
1–5 of 212